stockrow
Friday 6 November 2026
Export NVST’s income statement to Excel — free account
Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
24.98
2.21
−8.13%
Follow NVST
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 3 | 3 | 4 | 8 | 4 | — | — | — | — |
P/E ratio |
77.54 | 0.00 | 0.00 | 22.79 | 21.25 | 168.65 | 18.44 | 5.52 | 5.52 | 5.52 |
Altman Z-Score |
1.59 | 0.73 | 1.70 | 2.12 | 2.48 | 1.33 | 1.50 | — | — | — |
P/S ratio |
1.34 | 1.32 | 1.57 | 2.15 | 2.90 | 2.79 | 1.77 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
15.80 | 10.97 | 17.99 | 50.15 | 22.81 | 22.29 | 12.56 | 8.96 | 8.96 | 8.96 |
Altman Z″-Score (non-manufacturers) |
2.63 | 0.79 | 3.10 | 2.73 | 2.86 | 1.25 | 2.04 | — | — | — |
P/Operating CF |
33.77 | 25.09 | 39.43 | 50.15 | 53.41 | 27.84 | 21.59 | 29.37 | 29.37 | 29.37 |
Beneish M-Score |
(2.50) | (3.98) | (2.74) | (2.24) | (2.40) | (3.03) | (3.35) | — | — | — |
P/B ratio |
1.17 | 1.13 | 0.96 | 1.32 | 1.79 | 1.45 | 1.14 | 0.74 | 0.74 | 0.74 |
Price to Tangible BV |
30.17 | 144.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | 0.74 | 0.74 |
EV/Sales |
1.47 | 1.45 | 1.79 | 2.45 | 2.99 | 3.26 | 2.25 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
10.78 | 0.00 | 23.13 | 12.99 | 15.59 | 28.59 | 12.76 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
14.51 | 10.84 | 16.67 | 34.52 | 20.76 | 22.15 | 12.96 | 6.97 | 6.97 | 6.97 |
EV/FCF |
17.32 | 12.04 | 20.55 | 57.17 | 23.57 | 26.04 | 16.03 | 8.96 | 8.96 | 8.96 |
Quick Ratio |
1.93 | 1.63 | 1.73 | 0.81 | 1.16 | 0.71 | 0.92 | 0.72 | 0.74 | — |
Current Ratio |
2.38 | 2.04 | 2.23 | 1.15 | 1.52 | 0.94 | 1.41 | 1.23 | 1.27 | — |
Net Debt/EBITDA |
0.64 | (0.37) | 2.89 | 1.59 | 0.50 | 4.12 | 2.76 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
25.50% | 26.06% | 22.91% | 20.96% | 20.01% | 26.10% | 21.51% | 0.00% | 0.00% | — |
Debt/Equity |
0.47 | 0.48 | 0.36 | 0.33 | 0.32 | 0.48 | 0.37 | 0.00 | 0.00 | — |
Asset Turnover |
0.49 | 0.42 | 0.39 | 0.39 | 0.37 | 0.30 | 0.38 | 0.97 | 0.48 | 0.00 |
Operating CF/Net income |
5.87 | (0.30) | (2.75) | 0.75 | 1.06 | 8.53 | 1.83 | 1.73 | 1.19 | 1.53 |
Capex/Depreciation |
(0.29) | (0.21) | (0.31) | (0.44) | (0.25) | (0.24) | (0.45) | (0.56) | (0.40) | 0.00 |
Interest Coverage |
5.90 | (22.37) | 0.50 | 8.31 | 5.66 | 0.70 | 67.34 | — | — | — |
| 1.56% | (31.47%) | (2.39%) | 5.88% | 8.75% | 0.92% | 5.20% | 4.70% | 6.14% | 0.00% | |
| 0.85% | (18.71%) | (1.52%) | 3.69% | 5.06% | 0.51% | 3.63% | 7.90% | 5.09% | 0.00% | |
ROIC |
4.04% | (19.90%) | 0.41% | 4.01% | 4.45% | 0.59% | 3.16% | 3.86% | 0.00% | — |
Return on Tangible Assets |
3.20% | (94.27%) | (7.87%) | 50.49% | 38.19% | 18.45% | 37.32% | 56.63% | 75.65% | 0.00% |
Average Days of Receivables |
57.66 | 52.77 | 57.95 | 55.91 | 48.29 | 57.08 | 70.87 | 59.00 | 60.12 | 0.00 |
Research and Development Expense of Revenue |
4.19% | 3.95% | 3.65% | 3.90% | 4.01% | 4.49% | 5.83% | 6.05% | 6.13% | 5.13% |
Selling, General and Administrative Expense of Revenue |
42.53% | 46.12% | 41.18% | 41.08% | 40.65% | 47.93% | 42.91% | 39.78% | 37.79% | 37.09% |
Intangible Assets out of Total Assets |
0.53 | 0.54 | 0.64 | 0.70 | 0.64 | 0.63 | 0.75 | 0.81 | 0.00 | — |
Share Based Compensation of Revenue |
1.38% | 1.41% | 1.20% | 1.19% | 1.12% | 1.17% | 0.81% | 0.47% | 0.44% | 0.00% |
Graham Net Nets |
(0.15) | (0.19) | (0.17) | (0.17) | (0.09) | (0.29) | (0.40) | 0.22 | 0.22 | 0.22 |
Graham Number |
10.79 | 0.00 | 0.00 | 29.42 | 34.65 | 10.24 | 30.67 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.29% | (33.64%) | (2.28%) | 4.39% | 4.70% | 0.59% | 5.42% | 18.10% | 18.10% | 18.10% |
Free Cash Flow Yield |
6.33% | 9.12% | 5.56% | 1.99% | 4.38% | 4.49% | 7.96% | 11.16% | 11.16% | 11.16% |
Revenue per Share |
16.19 | 14.58 | 15.38 | 15.77 | 15.56 | 12.09 | 16.78 | 22.24 | 21.98 | 17.52 |
Operating CF per Share |
1.64 | 1.95 | 1.65 | 1.12 | 2.24 | 1.78 | 2.92 | 3.13 | 2.81 | 2.62 |
Capex per Share |
(0.27) | (0.20) | (0.31) | (0.44) | (0.27) | (0.27) | (0.56) | (0.56) | (0.38) | 0.00 |
Free Cash Flow per Share |
1.37 | 1.76 | 1.34 | 0.68 | 1.98 | 1.51 | 2.36 | 2.56 | 2.43 | 2.62 |
Cash per Share |
7.21 | 6.21 | 5.63 | 3.73 | 6.66 | 5.57 | 1.55 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
18.49 | 17.04 | 25.01 | 25.83 | 25.17 | 23.31 | 26.01 | 37.74 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
18.49 | 17.04 | 25.01 | 25.83 | 25.17 | 23.31 | 26.01 | 37.74 | 0.00 | 0.00 |
Free Cash Flow |
230.90 | 302.80 | 223.60 | 110.30 | 318.50 | 241.50 | 321.30 | 327.90 | 310.30 | 417.00 |
Working Capital |
1,174.00 | 909.60 | 962.90 | 187.90 | 627.60 | (94.10) | 292.70 | 145.80 | 167.00 | — |
Capital Expenditures |
(44.80) | (33.70) | (52.10) | (72.40) | (43.10) | (42.40) | (76.20) | (72.20) | (48.80) | (49.10) |
Net Current Asset Value |
(546.10) | (627.40) | (687.50) | (955.50) | (680.40) | (1,564.40) | (1,613.60) | (228.40) | 795.00 | — |
EV/EBIT |
18.51 | 0.00 | 145.89 | 19.76 | 24.51 | 144.57 | 21.85 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.00 |
Price to Operating Income |
16.88 | 0.00 | 127.69 | 17.33 | 23.72 | 123.75 | 17.13 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 0.58 | 0.54 | 0.57 | 0.66 | 0.64 | 0.58 | 0.50 | 0.53 | 0.00 |
Cash ROIC |
4.00% | 5.61% | 3.37% | 1.78% | 4.94% | 3.77% | 6.33% | 6.79% | 0.00% | 0.00% |
Accounts Receivable Turnover |
6.86 | 6.52 | 6.41 | 7.08 | 7.92 | 5.18 | 5.06 | 6.16 | 6.09 | 0.00 |
Accounts Payable Turnover |
6.73 | 6.43 | 5.52 | 5.29 | 5.58 | 4.26 | 4.40 | 5.66 | 10.03 | 9.88 |
Inventory Turnover |
4.66 | 4.55 | 4.02 | 3.88 | 4.51 | 3.54 | 3.36 | 4.48 | 8.91 | 8.78 |
Average Days of Payables |
56.73 | 56.01 | 58.19 | 76.15 | 62.65 | 84.54 | 81.15 | 63.85 | 68.11 | 4.76 |
Days of Inventory on Hand |
85.30 | 77.30 | 83.89 | 100.33 | 88.96 | 90.18 | 108.42 | 81.86 | 84.68 | (2.77) |
Average Receivables |
396.30 | 385.25 | 400.50 | 362.70 | 316.80 | 372.65 | 451.70 | 461.40 | 461.50 | — |
Average Payables |
183.10 | 177.05 | 203.90 | 207.05 | 194.15 | 205.25 | 212.70 | 219.70 | 118.65 | 118.65 |
Average Inventory |
264.55 | 249.90 | 279.80 | 282.30 | 239.90 | 246.95 | 278.30 | 277.35 | 133.55 | 133.55 |
Average Assets |
5,514.75 | 5,977.80 | 6,596.05 | 6,580.60 | 6,725.10 | 6,517.15 | 5,999.95 | 2,920.80 | 5,917.50 | — |
Average Common Equity |
3,020.55 | 3,554.35 | 4,190.40 | 4,132.45 | 3,889.50 | 3,631.90 | 4,184.60 | 4,908.70 | 4,907.00 | — |
Columns are period end dates · fundamentals updated 4 Nov 2026